MedTrace Logo

Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea

NCT03524963 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-07-24

No results posted yet for this study

Summary

This is a randomized, open-label, multiple-dose, two-sequence, two-period crossover study to to compare the safety/tolerability and pharmacokinetics between Pletaal SR Cap. and Cilostan CR Tab. in healthy volunteers

Conditions

Interventions

DRUG

Cilostan CR Tab.

Cilostan CR Tab. 200mg once a day for 5 days

DRUG

Pletaal SR Cap.

Pletaal SR Cap. 200mg once a day for 5 days

Sponsors & Collaborators

  • Bundang CHA Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-07
Primary Completion
2018-05-30
Completion
2018-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03524963 on ClinicalTrials.gov